Clinical trial · Observational
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
NCT07140757CI-TRIAL-00105214recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 17, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260917-000001
Summary
Brief summary (as posted)
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Low Risk | — | UNRESOLVED | — |
| Papillary Thyroid Cancer | Thyroid Gland Papillary Carcinoma | ALIAS | 0.90 |
| Radiofrequency Ablation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Health- related Quality of Life Questionnaires
- timeFrame
- Through study completion; an average of 1 year
- description
- This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Eligibility Criteria 1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC 2. Participant is over 18 years and is either not a surgical candidate or has declined surgery. 3. Capable and willing to provide written informed consent 4. Participant has one of the following diagnoses: * Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment, * Biopsy-proven indeterminate nodules (AUS or follicular neoplasm) * Papillary thyroid carcinoma (PTC) without metastasis * Locally recurrent thyroid cancer (\< 2 cm). Exclusion Criteria 1. Participants meeting any of the following criteria will be excluded: 2. Participants considered unsuitable for RFA by the treating physician
References
Publications (0)
Data not yet available
No reference posted for this study.